Max Lafontan
Research Subjects
Max Lafontan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Cedric Moro
Institute of Metabolic and Cardiovascular Diseases (I2MC), Inserm, Univ Toulouse, UMR1297, Toulouse, France
4 shared publications Michel Berlan
4 shared publications- Michel Berlan
Obesity Research Unit, French National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale U858), Toulouse, France
3 shared publications Claire Thalamas
Centre d'Investigation Clinique Toulouse France
2 shared publications- Coralie Sengenès
University of Toulouse, CNRS UMR 5070, INSERM U1301, EFS, ENVT, Institut RESTORE, Toulouse, France
2 shared publications François Crampes
2 shared publications
Latest Publications
- 1 September 2008
- Published by Elsevier in Diabetes & Metabolism
- Vol. 34 (4) , 317-327
Impact of visceral adipose tissue on liver metabolism
- 1 September 2008
- Published by Elsevier in Diabetes & Metabolism
- Vol. 34 (4) , 317-327
Impact of visceral adipose tissue on liver metabolism
- 1 May 2008
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 19 (4) , 130-137
Control of lipolysis by natriuretic peptides and cyclic GMP
- 1 May 2008
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 19 (4) , 130-137
Control of lipolysis by natriuretic peptides and cyclic GMP
- Open Access
- 1 August 2007
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 293 (2) , R612-R617
Atrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans
Head-down bed rest (HDBR) increases plasma levels of atrial natriuretic peptide (ANP) and decreases norepinephrine levels. We previously demonstrated that ANP promotes lipid mobilization and utilization, an effect independent of sympathetic nervous system activation, when infused into lean healthy men at pharmacological doses. The purpose of the present study was to demonstrate that a physiological increase in ANP contributes to lipid mobilization and oxidation in healthy young men. Eight men were positioned for 4 h in a sitting (control) or in a HDBR position. Indexes of lipid mobilization and hormonal changes were measured in plasma. Extracellular glycerol, an index of lipolysis, was determined in subcutaneous adipose tissue (SCAT) with a microdialysis technique. A twofold increase in plasma ANP concentration was observed after 60 min of HDBR, and a plateau was maintained thereafter. Plasma norepinephrine decreased by 30–40% during HDBR, while plasma insulin and glucose levels did not change. The level of plasma nonesterified fatty acids was higher during HDBR. SCAT lipolysis, as reflected by interstitial glycerol, as well as interstitial cGMP, the second messenger of the ANP pathway, increased during HDBR. This was associated with an increase in blood flow observed throughout HDBR. Significant changes in respiratory exchange ratio and percent use of lipid and carbohydrate were seen only after 3 h of HDBR. Thus the proportion of lipid oxidized increased by 40% after 3 h of HDBR. The rise in plasma ANP during HDBR was associated with increased lipolysis in SCAT and whole body lipid oxidation. In this physiological setting, independent of increasing catecholamines, our study suggests that ANP contributes to lipid mobilization and oxidation in healthy young men.
- 1 August 2007
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 293 (2) , R612-R617
Open AccessAtrial natriuretic peptide contribution to lipid mobilization and utilization during head-down bed rest in humans
Head-down bed rest (HDBR) increases plasma levels of atrial natriuretic peptide (ANP) and decreases norepinephrine levels. We previously demonstrated that ANP promotes lipid mobilization and utilization, an effect independent of sympathetic nervous system activation, when infused into lean healthy men at pharmacological doses. The purpose of the present study was to demonstrate that a physiological increase in ANP contributes to lipid mobilization and oxidation in healthy young men. Eight men were positioned for 4 h in a sitting (control) or in a HDBR position. Indexes of lipid mobilization and hormonal changes were measured in plasma. Extracellular glycerol, an index of lipolysis, was determined in subcutaneous adipose tissue (SCAT) with a microdialysis technique. A twofold increase in plasma ANP concentration was observed after 60 min of HDBR, and a plateau was maintained thereafter. Plasma norepinephrine decreased by 30–40% during HDBR, while plasma insulin and glucose levels did not change. The level of plasma nonesterified fatty acids was higher during HDBR. SCAT lipolysis, as reflected by interstitial glycerol, as well as interstitial cGMP, the second messenger of the ANP pathway, increased during HDBR. This was associated with an increase in blood flow observed throughout HDBR. Significant changes in respiratory exchange ratio and percent use of lipid and carbohydrate were seen only after 3 h of HDBR. Thus the proportion of lipid oxidized increased by 40% after 3 h of HDBR. The rise in plasma ANP during HDBR was associated with increased lipolysis in SCAT and whole body lipid oxidation. In this physiological setting, independent of increasing catecholamines, our study suggests that ANP contributes to lipid mobilization and oxidation in healthy young men.
- 1 December 2006
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 6 (6) , 580-585
Role of adipokines in the control of energy metabolism: focus on adiponectin
- 1 December 2006
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 6 (6) , 580-585
Role of adipokines in the control of energy metabolism: focus on adiponectin
- 1 October 2005
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (10) , 2032-2042
An Unsuspected Metabolic Role for Atrial Natriuretic Peptides
In normal and obese humans, lipid mobilization and systemic nonesterified fatty acid levels are thought to be acutely controlled by catecholamines (ie, epinephrine and norepinephrine) and insulin. Natriuretic peptides (NPs) are known to play a key role in the regulation of salt and water balance and blood pressure homeostasis. They are involved in the pathophysiology of hypertension and heart failure. NPs have recently been found to exert potent lipolytic effects (ie, activating the breakdown of stored triacylglycerols) in isolated human fat cells and to promote lipid mobilization in vivo. Atrial natriuretic peptide increases the intracellular 3′, 5′-cyclic guanosine monophosphate (cGMP) concentration which activates cGMP-dependent protein kinase leading to perilipin and hormone-sensitive lipase phosphorylation and lipolysis. NPs promote lipid mobilization when administered intravenously. NPs are also responsible for the residual lipid-mobilizing action observed under oral β-blockade in subjects performing physical exercise. NPs are therefore novel factors which may open promising research pathways to explain the control of lipid mobilization in physiological and pathological conditions. The metabolic impact of altered production and circulation of NPs remains to be established. The potential influence of NPs on the development of lipid disorders, obesity-related cardiovascular events, and cardiac cachexia will be discussed in this review.
- 1 October 2005
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (10) , 2032-2042
An Unsuspected Metabolic Role for Atrial Natriuretic Peptides
In normal and obese humans, lipid mobilization and systemic nonesterified fatty acid levels are thought to be acutely controlled by catecholamines (ie, epinephrine and norepinephrine) and insulin. Natriuretic peptides (NPs) are known to play a key role in the regulation of salt and water balance and blood pressure homeostasis. They are involved in the pathophysiology of hypertension and heart failure. NPs have recently been found to exert potent lipolytic effects (ie, activating the breakdown of stored triacylglycerols) in isolated human fat cells and to promote lipid mobilization in vivo. Atrial natriuretic peptide increases the intracellular 3′, 5′-cyclic guanosine monophosphate (cGMP) concentration which activates cGMP-dependent protein kinase leading to perilipin and hormone-sensitive lipase phosphorylation and lipolysis. NPs promote lipid mobilization when administered intravenously. NPs are also responsible for the residual lipid-mobilizing action observed under oral β-blockade in subjects performing physical exercise. NPs are therefore novel factors which may open promising research pathways to explain the control of lipid mobilization in physiological and pathological conditions. The metabolic impact of altered production and circulation of NPs remains to be established. The potential influence of NPs on the development of lipid disorders, obesity-related cardiovascular events, and cardiac cachexia will be discussed in this review.
- 22 September 2005
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 45 (1) , 119-146
FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity
▪ Abstract For a long time neural and endocrine messages were studied for their impact on adipocyte metabolism and control of storage/release of fatty acids. In fact, bidirectional communication exists between adipocytes and other tissues. Several molecules secreted from adipocytes are involved in fat cell signaling to other tissues. Adipocyte products could initiate antagonistic effects on target tissues. Fat cells produce peptides that can elicit insulin resistance, such as tumor necrosis factor-α and resistin, as well as hormones that can improve insulin resistance, such as leptin and adiponectin. Secretion of complement proteins, proinflammatory cytokines, procoagulant, and acute phase reactant proteins have also been observed in adipocytes. There is much to learn about how these signals function. It is unlikely that all the adipocyte's endocrine and paracrine signals have been identified. Putative pharmacological strategies aiming at modulation of afferent and efferent fat cell messages are reviewed and discussed.
- 22 September 2005
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 45 (1) , 119-146
FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity
▪ Abstract For a long time neural and endocrine messages were studied for their impact on adipocyte metabolism and control of storage/release of fatty acids. In fact, bidirectional communication exists between adipocytes and other tissues. Several molecules secreted from adipocytes are involved in fat cell signaling to other tissues. Adipocyte products could initiate antagonistic effects on target tissues. Fat cells produce peptides that can elicit insulin resistance, such as tumor necrosis factor-α and resistin, as well as hormones that can improve insulin resistance, such as leptin and adiponectin. Secretion of complement proteins, proinflammatory cytokines, procoagulant, and acute phase reactant proteins have also been observed in adipocytes. There is much to learn about how these signals function. It is unlikely that all the adipocyte's endocrine and paracrine signals have been identified. Putative pharmacological strategies aiming at modulation of afferent and efferent fat cell messages are reviewed and discussed.
- 1 January 2005
- Published by EDP Sciences in Médecine & Nutrition
- Vol. 41 (2) , 69-77
Comment optimiser l’utilisation des lipides pendant un exercice physique ? Effet de l’entraînement et différences sexuelles
- 1 January 2005
- Published by EDP Sciences in Médecine & Nutrition
- Vol. 41 (2) , 69-77
Comment optimiser l’utilisation des lipides pendant un exercice physique ? Effet de l’entraînement et différences sexuelles
- 1 January 2005
- Published by EDP Sciences in Médecine & Nutrition
- Vol. 41 (1) , 9-20
Les récepteurs adrénergiques de l'adipocyte : quelles implications dans l'obésité ?
Médecine & Nutrition est un journal pivot pluridisciplinaire qui rassemble les communications des spécialistes de la nutrition, des chercheurs de l#&39;agro-alimentaire, des médecins spécialistes
- 1 January 2005
- Published by EDP Sciences in Médecine & Nutrition
- Vol. 41 (1) , 9-20
Les récepteurs adrénergiques de l'adipocyte : quelles implications dans l'obésité ?
Médecine & Nutrition est un journal pivot pluridisciplinaire qui rassemble les communications des spécialistes de la nutrition, des chercheurs de l#&39;agro-alimentaire, des médecins spécialistes
- 31 July 2003
- Published by Elsevier in Pathologie Biologie
- Vol. 51 (5) , 238-240
Activités métaboliques et sécrétoires des adipocytes
- 31 July 2003
- Published by Elsevier in Pathologie Biologie
- Vol. 51 (5) , 238-240
Activités métaboliques et sécrétoires des adipocytes
- 1 June 2003
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (6) , 276-283
Do regional differences in adipocyte biology provide new pathophysiological insights?
- 1 June 2003
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (6) , 276-283
Do regional differences in adipocyte biology provide new pathophysiological insights?